- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01210118
Interventions of Smoking Cessation During Pregnancy
The Effectiveness of High and Low Intensity Intervention for Smoking Cessation During Pregnancy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial that compares the efficacy of a proactive pregnancy-tailored high intensity intervention for smoking cessation, with a usual care low intensity intervention, that is the control condition.
Intervention group participants will receive a high intensity intervention, which includes: 30 minutes of cognitive-behavioural intervention delivered by a trained health care professional through out the first 24 weeks of gestation and a self-help manual especially tailored for smoking cessation during pregnancy. Control group participants will receive 5 minutes of low intensity intervention.
Participants' smoking status will be biochemically validated with urine cotinine and nicotine both at the baseline and at the 32nd week of gestation, expired carbon monoxide (CO) will be measured only at the baseline. After childbirth the infants' birth weight, the premature birth and any other complications in pregnancy and childbirth will be recorded. No medication is going to be used.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Attiki
-
Athens, Attiki, Greece
- Peripheral General Hospital-Maternity Helena Venizelos
-
Haidari, Attiki, Greece, 12462
- Maternity Unit of ATTIKON University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women
- current cigarette smoker (smoked >5 cigarettes in the past 7 days)
- 18 years old or older
Exclusion Criteria:
- More than 24 weeks' gestation at study entry
- No telephone access
- Not planning to live in Athens for 1 year
- Unable to read and speak Greek
- Alcoholics
- Use of drug substances
- Depression
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High intensity intervention
Experimental group participants received a higher intensity intervention, which include: 30 minutes of individualized cognitive-behavioural counselling delivered by a trained health care professional and a self-help manual especially tailored for smoking cessation during pregnancy.
Counseling was based at the "5 Αs" (Ask,Advise, Asses, Assist, Arrange).
In addition to counselling, a self help manual especially tailored for smoking cessation during pregnancy for Greek women was provided.
|
Experimental group participants received a higher intensity intervention, which include: 30 minutes of individualized cognitive-behavioural counselling delivered by a trained health care professional and a self-help manual especially tailored for smoking cessation during pregnancy.
Counseling was based at the "5 Αs" (Ask,Advise, Asses, Assist, Arrange).
In addition to counselling, a self help manual especially tailored for smoking cessation during pregnancy for Greek women was provided.
Other Names:
|
Other: Low intensity intervention
Control group participants received a face to face low intensity intervention which lasted 5 minutes and included brief advice and the provision of a leaflet on smoking and pregnancy.
This leaflet summarized the main effects of smoking during pregnancy and gave clear short messages for encouraging smoking cessation by setting up a quit date.
|
Control group participants received a face to face low intensity intervention which lasted 5 minutes and included brief advice and the provision of a leaflet on smoking and pregnancy.
This leaflet summarized the main effects of smoking during pregnancy and gave clear short messages for encouraging smoking cessation by setting up a quit date.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participants' Smoking Status
Time Frame: around the 32nd week of gestation.
|
participants' smoking status was validated by urine cotinine and urine nicotine
|
around the 32nd week of gestation.
|
The Effectiveness of the Interventions According the Levels of Urine Cotinine Before and After Intervention.
Time Frame: At the baseline and at the 32nd week of gestation
|
The basic primary outcomes of the study present the levels of urine cotinine before and after intervention separately for each group according to the cut of point that is used for the separation of active from passive smoking ,when urine cotinine ≤80ng/ml: there is biochemically validated smoking cessation.
|
At the baseline and at the 32nd week of gestation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Birth Weight
Time Frame: After child birth
|
Infants' birth weight was recorded.
|
After child birth
|
Days of Prematurity of Birth
Time Frame: After child birth
|
Days of prematurity of birth were recorded
|
After child birth
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Panagiotis K Behrakis, Professor, National and Kapodistrian University of Athens
- Principal Investigator: Andriani N Loukopoulou, PhD pending, National and Kapodistrian University of Athens
Publications and helpful links
General Publications
- Loukopoulou A N, Evangelopoulou V, Behrakis P K.Smoking and pregnancy. Pneumon 23(2):160-167,2010.
- Loukopoulou AN, Vasiliou MP, Behrakis PK. (2011) Interventions for smoking cessation during Pregnancy Pneumon, 24(1):381-391(Review).
- Loukopoulou AN, Vardavas CI, Farmakides G, Rossolymos C, Chrelias C, Tzatzarakis MN, Tsatsakis A, Lymberi M, Connolly GN, Behrakis PK. Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE). BMC Public Health. 2011 Dec 6;11:903. doi: 10.1186/1471-2458-11-903.
- Loukopoulou AN, Vardavas CI, Farmakides G, Rosolymos C, Chrelias C, Tzatzarakis M, Tsatsakis A, Myridakis A, Lyberi M, Behrakis PK. Counselling for smoking cessation during pregnancy reduces tobacco-specific nitrosamine (NNAL) concentrations: A randomized controlled trial. Eur J Midwifery. 2018 Nov 14;2:14. doi: 10.18332/ejm/99546. eCollection 2018.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PBAL001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
-
Johns Hopkins UniversityMaryland Department of Health and Mental HygieneCompletedCOach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)Smoking | Smoking CessationUnited States
Clinical Trials on Higher intensity intervention
-
AHS Cancer Control AlbertaUniversity of CalgaryCompletedBreast Cancer SurvivorshipCanada
-
McMaster UniversityCanadian Frailty NetworkCompleted
-
University of GeorgiaCompletedMetabolic SyndromeUnited States
-
NYU Langone HealthCompletedGeneralized Anxiety Disorder | Social Anxiety | Panic DisorderUnited States
-
University of TorontoUnknownPostpartum WomenCanada
-
Centre for Addiction and Mental HealthThe Hospital for Sick Children; University of Toronto; Trillium Health Centre; Medical...CompletedPsychosis | Cardiovascular Risk Factor | Metabolic DiseaseCanada
-
VA Office of Research and DevelopmentCompletedStroke | Cerebrovascular AccidentUnited States
-
University of UtahDepartment of Health and Human ServicesCompletedObesity | Diabetes | Physical ActivityUnited States
-
Denver Health and Hospital AuthorityWashington University School of Medicine; Vanderbilt University Medical Center and other collaboratorsNot yet recruitingPediatric Infectious Disease | Acute Otitis Media | Ear Infection